Kathmere Capital Management LLC Grows Stake in Relx Plc (NYSE:RELX)

Kathmere Capital Management LLC lifted its stake in shares of Relx Plc (NYSE:RELX) by 1.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,398 shares of the technology company’s stock after purchasing an additional 481 shares during the period. Kathmere Capital Management LLC’s holdings in Relx were worth $882,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Bank of America Corp DE increased its stake in shares of Relx by 1.2% during the fourth quarter. Bank of America Corp DE now owns 6,279,226 shares of the technology company’s stock worth $174,060,000 after purchasing an additional 75,685 shares in the last quarter. Personal CFO Solutions LLC grew its stake in Relx by 4.0% during the 1st quarter. Personal CFO Solutions LLC now owns 9,425 shares of the technology company’s stock valued at $306,000 after acquiring an additional 359 shares in the last quarter. Penserra Capital Management LLC grew its stake in Relx by 266.7% during the 1st quarter. Penserra Capital Management LLC now owns 16,335 shares of the technology company’s stock valued at $529,000 after acquiring an additional 11,880 shares in the last quarter. Eagle Ridge Investment Management grew its stake in Relx by 2.8% during the 1st quarter. Eagle Ridge Investment Management now owns 306,935 shares of the technology company’s stock valued at $9,957,000 after acquiring an additional 8,311 shares in the last quarter. Finally, LPL Financial LLC grew its stake in Relx by 12.9% during the 4th quarter. LPL Financial LLC now owns 98,145 shares of the technology company’s stock valued at $2,721,000 after acquiring an additional 11,221 shares in the last quarter. Hedge funds and other institutional investors own 3.56% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on RELX. Barclays upped their price objective on shares of Relx from GBX 2,585 ($32.35) to GBX 2,700 ($33.79) in a research note on Monday, July 3rd. Morgan Stanley boosted their target price on shares of Relx from GBX 2,930 ($36.67) to GBX 2,960 ($37.04) in a report on Friday, July 28th. JPMorgan Chase & Co. boosted their target price on shares of Relx from GBX 3,100 ($38.79) to GBX 3,170 ($39.67) in a report on Wednesday. StockNews.com initiated coverage on shares of Relx in a report on Thursday, August 17th. They issued a “hold” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Relx from GBX 2,100 ($26.28) to GBX 2,200 ($27.53) in a report on Friday, July 28th.

Relx Stock Performance

Shares of RELX stock opened at $34.64 on Friday. The firm’s 50 day moving average price is $32.86 and its 200-day moving average price is $32.27. The company has a debt-to-equity ratio of 1.62, a quick ratio of 0.42 and a current ratio of 0.48. Relx Plc has a one year low of $23.39 and a one year high of $34.88. The firm has a market cap of $65.53 billion, a P/E ratio of 22.49, a P/E/G ratio of 2.42 and a beta of 0.84.

Relx Cuts Dividend

The firm also recently announced a semi-annual dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 4th were issued a dividend of $0.2195 per share. The ex-dividend date of this dividend was Thursday, August 3rd. This represents a yield of 2.1%. Relx’s dividend payout ratio (DPR) is presently 27.27%.

About Relx

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.